UCD pharma firm developing a disease-modifying drug for cardiopulmonary disease.
| Date | Round | Amount |
|---|---|---|
| Oct 2022 | Grant Dublin pharma firm Atxa Therapeutics was selected for EIC Accelerator blended grant-and-equity funding (part of €24.3m across three Irish firms). | — |